INTRODUCTION
Neutrophils are the dominant white blood cells in the human body, and they play a significant role in the first line immunological response. 1 Neutrophil dysfunction is often found to be involved in neutrophilic inflammation, including acute severe subtypes of asthma 2, 3 and chronic obstructive pulmonary disease (COPD), 4, 5 ranking as the fourth leading cause of death worldwide. 6 Despite the fact that neutrophilic inflammation endangers human health, only a few pharmacological treatments are available and effective to treat neutrophilic inflammation. The pathophysiology of neutrophilic inflammation is characterized by neutrophil accumulation around infection sites due to aberrant neutrophil chemotaxis and impaired apoptotic pathways; 5, 7 as such, there is a clear need to understand the underlying neutrophil biology in hopes of developing alternative approaches to slow neutrophil chemotaxis and remove persistent neutrophils. 8 Chemotaxis is a dynamic process whereby cells move in response to chemical gradients of signaling molecules called chemokines. Interleukin-8 (IL-8), one of the most well-documented primary chemokines that regulates neutrophil movement, is responsible for promoting neutrophil chemotaxis and activating the pathogenesis of neutrophil inflammatory diseases. 9, 10 The neutrophil intracellular pathway triggered by IL-8 offers several pharmaceutical targets, such as the receptor chemokine C-X-C motif receptor-2 (CXCR2), the signal transducer enzyme phosphoinositide 3-kinase (PI3K), and intracellular free Ca 2+ , all of which perform important functions in the neutrophil chemotactic cascade (Fig. 1 ). IL-8 initiates neutrophil chemotaxis through binding to seven-transmembrane domain receptors (CXCR1 and CXCR2) located on the surface of neutrophils. Although activation of both CXCR1 and CXCR2 is able to initiate a series of neutrophil signaling processes, the rate of receptor internalization is more rapid with CXCR2 than CXCR1, and a lower dose of IL-8 is required for CXCR2 activation. 11, 12 Following the translocation of CXCR receptors to the cytoplasmic granules mediated by G proteins, which are a family of proteins transmitting signals from extracellular stimuli to the interior of the cell -Gβγ subunits activate PI3K and phospholipase C (PLC) pathways to govern downstream signal transduction elements. PI3K and its main lipid products are involved in a variety of cellular processes, such as cell survival, cytoskeleton rearrangement, and cell transformation; more importantly, PI3K is responsible for the cell polarization that controls the direction of neutrophil migration. 13 PLC-molecules can be divided into three categories (β, γ and δ), and the activation of the PLC-β isoform not only mediates the function of protein kinases, but also leads to an increased level of intracellular free Ca 2+ . 14 The relationship between Ca 2+ and chemotaxis is still in dispute, although it has been suggested that Ca 2+ is involved in the contraction of the cell rear and uropod, which is an underlying step in the movements of cells. 15 Clarification of the role of Ca 2+ in neutrophil chemotaxis is necessary to understand and manipulate the signaling pathway.
In this work, we exploit single cell bioanalytical approaches to evaluate the physiological effects of three drugs aimed at the aforementioned targets. Inhibition of CXCR2 function with an antagonist downregulates the neutrophil migratory response in the biological cascade, potentially decreasing the number of cells infiltrating sites of interest. A number of CXCR2 antagonists have been identified by pharmaceutical companies, and some of them are already in preclinical trials. 16 SB225002, a common CXCR2 antagonists, was employed herein to determine the impacts of receptor antagonism on neutrophil chemotaxis and viability. The PI3K inhibitor, LY294002, has been studied extensively during the past two decades; 17, 18 however, the precise role of this inhibitor in neutrophil chemotaxis, including temporal regulation and concentration selection, is still not clear.
Also, LY294002 is expected to suppress neutrophil viability since PI3K has been identified as a survival factor for neutrophils. 19 The connection between neutrophil chemotaxis and cytosolic Ca 2+ levels can be determined by introducing the drug considered to influence both chemotactic behaviors and the mobilization of intracellular Ca 2+ . Theophylline is a common respiratory drug that alleviates the symptoms of COPD patients. Previous research has revealed that theophylline induces the inhibition of neutrophil chemotaxis in both healthy control and patient samples, 20, 21 likely by 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Furthermore, compared to the simplistic environment in traditional methods, microfluidic techniques sustain a more complicated in vivo-like milieu with dynamic fluid flow and complex biological media so that cellular behaviors can be monitored in a physiologically relevant environment. 
Methods

Device Fabrication
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Microfluidic devices were fabricated using standard photolithography protocols. Following photomask fabrication, a 4-inch silicon wafer was spin-coated with 100 μm thick negative photoresist SU-8 50 (Microchem, Newton, MA) and then underwent the first baking step. The channel patterns were then copied to the SU-8 mold through the previously prepared photomask by UV exposure. After the second baking process, the silicon wafer was developed in SU-8 developer (Microchem, Newton, MA) to dissolve the unexposed photoresist, and the device patterns remained on the substrate. A mixture of Sylgard 184 silicone elastomer base and curing agent (Ellsworth Adhesives, Germantown, WI) in 10:1 mass ratio was slowly poured on the completed SU-8 mold after degassing, and then incubated on the hot plate at 95°C overnight. The polydimethylsiloxane (PDMS) layer was cut and punched for inlet and outlet holes.
Finally, the PDMS layer was attached to the glass substrate permanently using oxygen 
plasma at 100 L/h oxygen flow rate and 100 W for 10 seconds. The fabricated devices were sterilized by injecting 70% v/v ethanol solution into channels and exposed to UV light overnight before use.
Neutrophil Isolation
Freshly drawn whole human blood samples with ethylenediaminetetraacetic acid (EDTA)
as an anticoagulant were prepared by Memorial Blood Center (St. Paul, MN) according to IRB protocol E&I ID no. 07809. All the samples were collected from healthy donors as demonstrated by a screening questionnaire that meets the Food and Drug Administration (FDA) guidelines, and neutrophil isolation was performed immediately following blood draws. 5 mL of blood sample was layered carefully over the same volume of mono-poly resolving medium (Fisher Scientific, Waltham, MA) and centrifuged to obtain distinct density gradients. The neutrophil band was collected and purified using red blood cell lysis buffer (Miltenyi Biotec Inc., Auburn, CA) according to the previously reported protocol. 27 The final neutrophil pellet was re-suspended in Hank's buffered salt solution (HBSS, Fisher Scientific, Waltham, MA) containing 2% human serum albumin (HSA, Sigma-Aldrich, St. Louis, MO).
Cell Viability Assay
Pure neutrophils were diluted to the density of 6 × 10 5 cells/mL in HBSS medium and seeded in 96-well plate with 100 μL in each well. Neutrophils were incubated with different concentrations of drugs (CXCR2 antagonist SB225002, EMD Millipore, Billerica, MA; PI3K inhibitor LY294002 or theophylline, Sigma-Aldrich, St. Louis, MO) (1)
Fluorescence Imaging and Microfluidic Chemotaxis Experiments
The fluorescence imaging was undertaken by injecting 100 μM Rhodamine 6G (Sigma-Aldrich, St. Louis, MO) solution through the right medium inlet and HBSS buffer through the left medium inlet. The flow rates were kept at 100 μL/h to obtain stable fluorescence gradients in the cell culture chamber.
Prior to doing chemotaxis experiments, the channels were rinsed with sterilized Milli-Q 
Analysis of Chemotaxis Data
In the cell culture chamber, the trajectories of 15 or more randomly-chosen neutrophils were analyzed ( Fig. 2(a) ). Neutrophil chemotaxis was quantified using three parameters, motility index (MI), chemotactic index (CI), and effective chemotactic index (ECI), 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript which have been employed to describe neutrophil chemotaxis previously. 28 The MI value describes the total possible movement of neutrophils and is defined as the ratio of final straight migratory distance (d final ) and the maximum displacement (d max ).
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where d max is the product of average velocity of the tracked cell and total observed time.
CI represents the orientation of neutrophils during migration and is defined as the ratio of the final distance in the gradient direction (d x ) and the entire migration distance of a cell
The third parameter, ECI, is defined as the product of MI and CI, and depicts the overall effectiveness of neutrophil chemotaxis. These three parameters from individual neutrophils were calculated and plotted as histograms reflecting average values and standard error of the mean (SEM). Unpaired t-tests with α=0.05 were used for statistical comparison.
Calcium Imaging
Neutrophils were prepared in HBSS buffer containing 2% HSA at the density of 4-5 × 10 6 cells/mL. For loading cells with the intracellular Ca 2+ -sensitive fluorophore fura-2 AM (Sigma-Aldrich, St. Louis, MO), 1 mL of neutrophil suspension was incubated with 1 μL of 1 mM fura-2 AM at 37°C under 5% CO 2 for 30 min. Neutrophils were centrifuged twice to remove extra fura-2 AM, and then divided into two tubes of 500 μL solution.
One population was re-suspended using Ca 2+ -free HBSS medium (Sigma-Aldrich, St. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript 
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where K d is the effective dissociation constant for the probe molecule (220 nM), S f2 is the minimum excitation intensity at 380 nm, and S b2 is the maximum excitation intensity at 380 nm. Neutrophil autofluorescence without added fura-2 AM was also measured 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript following the same procedures and subtracted in the calculation.
Results and Discussion
Confirmation of Chemical Gradients in Microfluidic Device
The microfluidic device is composed of three inlets, many serpentine channels, and one cell culture chamber (Fig. 2(b) ). At each node in the microfluidic serpentine channels, the fluid splits into two streams and mixes via diffusion, with the neighboring stream Analyst Accepted Manuscript 13 The effects of drugs, at varying doses and time periods, on neutrophil viability were evaluated using a traditional colorimetric MTT assay. The presence of 10 μM CXCR2
Neutrophil Viability after Drug Treatment
antagonist SB225002 for 100 μL of 6 × 10 5 cells/mL neutrophils induced about 40% decrease in neutrophil viability versus the control condition after 150 min incubation, while 30 and 90 min incubation times caused smaller decreases in viability ( Fig. 3(a) ).
These compromised viabilities are likely attributable completely to drug cytotoxicity as none of the incubation times are long enough to induce spontaneous neutrophil apoptosis. 31 In addition, the same trends of viability reduction were observed while exposed to 1 μM and 100 nM SB225002. These results imply that SB225002 blocks the surface receptor sites accompanied with the internalization of antagonist, resulting in decreased neutrophil viability. The introduction of the PI3K inhibitor LY294002 only reveals moderate cytotoxic effects on neutrophils. Approximately a 20% reduction in neutrophil viability was observed after 90 and 150 min treatment at all the concentrations, and 30 min incubation had almost no effect on neutrophil viability (Fig. 3(b) ). Previous studies suggested that PI3K played an important part in the anti-apoptotic system activated by granulocyte/macrophage colony-stimulating factor (GM-CSF), 32, 33 and LY294002 was revealed to suppress the survival effects of this cytokine. Since there was no GM-CSF in the neutrophil medium to activate the PI3K pathway, the cytotoxic effects of LY294002 on neutrophils were limited as precedent work suggests. The evaluation of neutrophil viability after theophylline incubation was also in agreement with the previous reports that indicated a significant drop in neutrophil viability. 34 Unlike the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript dose-dependent effects displayed in previous reports, neither the therapeutic plasma concentration (10 μM) nor excessive amounts of theophylline (100 μM and 1 mM) showed any reduction in neutrophil viability with 30 min incubation. For 90 min incubation, theophylline induced a 40% reduction in viability at all the three concentrations, and all the drug concentrations induced a 50% decrease in neutrophil viability with 150 min incubation (Fig. 3(c) 
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Neutrophil Chemotaxis with Drug Incubation
Instead of traditional chamber-based assays, neutrophil chemotaxis under a 0-10 ng/mL S1(a) and (b) ). The addition of 10 μM SB225002 resulted in a significant decrease in CI value after 90 and 150 min incubation while also causing an 80% decline in the ECI value after 150 min incubation (Fig. 4(a) ). These results suggest that CXCR2 antagonism has remarkable impacts on the direction and effectiveness of neutrophil chemotaxis in a concentration-and time-dependent fashion without altering neutrophil motility. The IC 50 of SB225002 for inhibiting neutrophil chemotaxis through CXCR2 antagonism is between 1 μM and 10 μM, which is much higher than the reported value (IC 50 = 22 nM). 37 This reported value was obtained using conventional chamber-based assays where all cells are assumed to be alive and responding to the chemokine signal; however, dead cells induced by CXCR2 antagonist cannot migrate into the chemokine chamber and are retained in the medium chamber. In this fashion, chamber-based assays overestimate the inhibitory effects of SB225002 on neutrophil chemotaxis by ignoring the cytotoxicity of the drug. On the contrary, defunct neutrophils cultured in the microfluidic device are removed by the fluid flow or barely move on the bottom; these cells were eliminated from the data analysis, and only effective neutrophil chemotaxis was collected and analyzed. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript Neutrophils exposed to varying concentrations of LY294002 showed distinct chemotactic behaviors. Similar to SB225002, 100 nM LY294002 had no major effect on neutrophil chemotaxis (Fig. S1(c) ), and 10 μM induced a significant decrease in the CI value after 150 min incubation (Fig. S1(d) ), which confirms the conclusion that PI3K regulates the cellular polarization in the IL-8 signaling pathway and LY294002 interrupts the PI3K-involved neutrophil migration. Meanwhile, 1 μM of LY294002 resulted in about a 70% reduction in CI signal after 150 min incubation as well as a statistically significant drop in ECI values after 90 and 150 min treatment (Fig. 4(b) ). These results suggest that PI3K modulates neutrophil chemotaxis via a positive feedback loop wherein two cytokines function both upstream and downstream of one another. Although there is no literature precedent for the involvement of PI3K in a positive feedback loop, the phospholipid product PtdInsP 3 and downstream Rho GTPases have been reported to activate each other in a positive feedback relationship. 38 Herein, we speculate that neutrophils exposed to 10 μM LY294002 are short of activated PI3K and PtdInsP 3 , which activates the positive feedback loop between PtdInsP 3 and Rho GTPases to stimulate the production of PtdInsP 3 , thus preventing the inhibitory effects of LY294002 . Unlike SB225002, the IC 50 of LY294002 for inhibiting neutrophil chemotaxis in this study was around 1 μM, close to the known value (IC50 = 1.4 μM), 39 since LY294002 induces smaller cytotoxic impacts on neutrophils than SB225002, and the contribution of cytotoxic effects to IC 50 is limited for LY294002. This also supports our belief that the cytotoxic effects of drugs must be considered in the measured IC 50 values. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Analyst Accepted Manuscript Theophylline, a current medication for COPD, indicates a completely opposite trend in neutrophil chemotaxis inhibition compared to the other drugs. At therapeutic concentration, 10 μM theophylline caused a significant decrease in MI value after 90 and 150 min incubation, with no significant change in CI and ECI values (Fig. 4(c) ). Two larger concentrations, 100 μM and 1 mM, did not indicate any significant difference in the three numerical parameters (Fig. S1 (e) and (f)), which suggests that theophylline only lowers the motility of neutrophils around the optimal concentration without any influence on the polarization and effectiveness of neutrophil chemotaxis. These results contradict the observation found in the previous studies that theophylline is a potent inhibitor for neutrophil chemotaxis. [20] [21] [22] As mentioned above, drug cytotoxicity can lead to overestimated chemotaxis in the traditional chamber-based assays by impeding neutrophil migration by increasing cell apoptosis rather than damaging chemotactic pathway.
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Theophylline induces a great drop in neutrophil viability instead of inhibiting neutrophil chemotaxis.
In sum, our results demonstrate that SB225002 and LY294002 decrease polarization and effectiveness of neutrophil chemotaxis at different optimal concentrations, but theophylline only decreases motility of neutrophils at therapeutic concentration.
Intracellular Calcium Imaging
To determine the role of Ca 2+ in neutrophil chemotaxis, the effects of theophylline on the mobilization of intracellular Ca 2+ during theophylline treatment were assessed using single cell ratiometric fluorescence imaging. In the medium containing Ca 2+ , the concentrations of intracellular Ca 2+ after 10 ng/mL IL-8 activation were determined at varying doses and theophylline incubation times. Compared to the control sample, the presence of 1 mM theophylline induced a significant decrease in intracellular Ca 2+ after 30 and 150 min incubation (Fig. 5(a) ), which indicates that theophylline suppresses the elevation of Ca 2+ level in the IL-8 signaling pathway. The fluorescence images clearly
show that the number of bright cells increases greatly after IL-8 stimulation without theophylline treatment (Fig. 5(c)) ; however, the elevation of intracellular Ca 2+ was almost totally inhibited with 1 mM theophylline treatment after 150 min ( Fig. 5(d) ). In addition to the high dose, 10 μM theophylline also significantly inhibited Ca 2+ increase after 90 min incubation. Although there is no statistically significant inhibition for 100 μM of theophylline, the average value of intracellular Ca 2+ level at each time point was lower than that of the control sample. Further examination with 500 μM and 50 μM theophylline also indicated significant decrease in intracellular Ca 2+ level after long time exposure (Fig. S2) , which reveals that the introduction of theophylline in a large concentration range inhibits the elevation of intracellular Ca 2+ activated by the chemokine IL-8. Combined with theophylline's apparent minimal effect on neutrophil chemotaxis, it appears that neutrophil chemotaxis is independent of the alteration in intracellular Ca 2+ .
In the Ca 2+ -free medium, no significant change in intracellular Ca 2+ levels was observed for any of the theophylline doses, accounting for the control cell behavior (where the influence of Ca 2+ in the media was significant (Fig. S3 ). After incubation with 1 mM theophylline for 150 min, the addition of digitonin, a cell-permeabilizing agent that allows entry of extracellular Ca 2+ , induced a tiny increase in Ca 2+ level; however, the addition of digitonin resulted in the maximum fluorescence for the control condition.
Conclusions
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